Author:
Menzies-Gow Andrew,Jackson David J.,Al-Ahmad Mona,Bleecker Eugene R.,Cosio Piqueras Francisco de Borja G.,Brunton Stephen,Canonica Giorgio Walter,Chan Charles K. N.,Haughney John,Holmes Steve,Kocks Janwillem,Winders Tonya
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference92 articles.
1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2021 Fontana, WI: Global Initiative for Asthma; 2021. https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Accessed June 2022.
2. Stanford RH, Shah MB, D’Souza AO, Dhamane AD, Schatz M. Short-acting beta-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109(6):403–7.
3. Spanish Society of Health Directors (SEDISA). Proyecto carabela: Caracterización del modelo asistencial de asma grave para la mejora de la eficiencia de las unidades de asma. 2021. https://sedisa.net/2021/02/09/proyecto-carabela-caracterizacion-del-modelo-asistencial-de-asma-grave-para-la-mejora-de-la-eficiencia-de-las-unidades-de-asma/. Accessed June 2022.
4. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed June 2022.
5. Nwaru BI, Ekstrom M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global sabina programme. Eur Respir J. 2020;55(4):1901872.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献